Mao, Yuling
Yao, Yachao
Du, Hongzi
Wang, Zheng
Zhou, Xueliang
Zeng, Ming
Wang, Chunyan
Liu, Hanyan
Luo, Yang
Hong, Honghai
Liu, Jianqiao
Li, Lei
Funding for this research was provided by:
the Guangzhou Basic and Applied Basic Research Project (2023A04J0579)
the Guangzhou Medical University Student Innovation Ability Enhancement plan (02-408-2203-2060)
the National Natural Science Foundation of China (82101732, 82101672, 81971452, 81871211)
Guangzhou Science and technology planning project (2060206)
Natural Science Foundation of Guangdong Province (2022A1515012513)
Guangzhou Science and Technology Projects (202102010050)
the National Key Research and Development Program of China (2022YFC2702504)
Article History
Received: 20 April 2023
Accepted: 24 October 2023
First Online: 22 November 2023
Declarations
:
: This study was approved by the ethics committee of the Third Affiliated Hospital of Guangzhou Medical University [Ethic no. (2023) 036]. Each patient has signed an informed consent on obtaining and analyzing their clinical data prior to the initiation of IVF/ICSI-ET treatment.
: The author confirms that the study described has not been published before, that its publication has been approved by all co-authors and that its publication has been approved (tacitly or explicitly) by the responsible authorities at the institution where the study was carried out.
: All authors have declared no conflict of interest.